Advertisement
Advertisement
U.S. markets open in 6 hours 30 minutes
Advertisement
Advertisement
Advertisement
Advertisement

G1 Therapeutics Inc (G1H.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
6.85-0.34 (-4.68%)
As of 08:06AM CET. Market open.
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
46,847
31,476
45,285
0
Cost of Revenue
3,130
2,016
-
-
Gross Profit
43,717
29,460
-
-
Operating Expense
186,594
171,917
141,761
129,041
Operating Income
-142,877
-142,457
-96,476
-129,041
Net Non Operating Interest Income Expense
-9,216
-4,624
-826
-
Other Income Expense
-372
-346
-542
6,594
Pretax Income
-152,465
-147,427
-97,844
-122,447
Tax Provision
1,465
925
1,410
-
Net Income Common Stockholders
-153,930
-148,352
-99,254
-122,447
Diluted NI Available to Com Stockholders
-153,930
-148,352
-99,254
-122,447
Basic EPS
-
-3.54
-2.62
-3.27
Diluted EPS
-
-3.54
-2.62
-3.27
Basic Average Shares
-
41,943
37,878
37,499
Diluted Average Shares
-
41,943
37,878
37,499
Total Operating Income as Reported
-142,877
-142,457
-96,476
-129,041
Total Expenses
189,724
173,933
141,761
129,041
Net Income from Continuing & Discontinued Operation
-153,930
-148,352
-99,254
-122,447
Normalized Income
-153,930
-148,352
-99,254
-122,447
Interest Income
278
43
952
-
Interest Expense
9,494
4,667
1,778
-
Net Interest Income
-9,216
-4,624
-826
-
EBIT
-142,971
-142,760
-96,066
-129,041
EBITDA
-142,464
-
-
-
Reconciled Cost of Revenue
3,130
2,016
-
-
Reconciled Depreciation
507
469
582
356
Net Income from Continuing Operation Net Minority Interest
-153,930
-148,352
-99,254
-122,447
Normalized EBITDA
-142,464
-142,291
-95,484
-128,685
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement